Clinical trials
No Disease or Condition is Being Studied clinical trials
Below are recruiting no disease or condition is being studied clinical trials, each written for real people, not researchers. We’re tracking 18,647 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07493967Enrolling by invitation
Stomach balloon for fatty liver disease study
This study looks at how a stomach balloon affects symptoms and quality of life in people with obesity and fatty liver disease. It will track your health over time to see if the balloon helps.
Dallas, TexasAges 18 years+ - NCT07488572Enrolling by invitationPhase 2
AK112 for advanced clear cell kidney cancer
This study tests a new drug called AK112 (Yiwoxidan Anti) in people with advanced clear cell kidney cancer who cannot take TKI medications. The goal is to see if it is safe and effective.
Guangzhou, GuangdongAges 18–75 - NCT07485816Enrolling by invitation
Heart-brain oxygen and thinking changes in heart failure
This study looks at how well your heart and brain work together to use oxygen, and how that relates to changes in thinking and memory for people with heart failure.
Kunming, YunnanAges 18–70 - NCT07480343Enrolling by invitation
Five-year follow-up after CREST glaucoma study
This study follows up with people who finished the CREST study to check how their eyes are doing 5 years later. It looks at the long-term results of a prior glaucoma treatment.
Newport Beach, CaliforniaAges Any age - NCT07479966Enrolling by invitation
Brain connectivity and placebo response study
This trial examines how brain connectivity relates to differences in how people respond to placebos. It may help understand individual responses to treatments.
Hamburg, Free and Hanseatic City of HamburgAges 18–35 - NCT07476807Enrolling by invitation
Using video calls to check skin reactions from cancer treatment
This study tests if video consultations can safely check skin side effects from chemotherapy or other cancer drugs. If you have a mild to moderate skin rash or reaction, you might be able to have a telemedicine visit instead of going to the hospital.
Sligo, SligoAges Any age - NCT07476313Enrolling by invitation
Testing a new home sleep system for moderate to severe sleep apnea
This study tests a home sleep testing system called SleepView+ in people who have already been scheduled for an overnight sleep lab study. If you have moderate to severe obstructive sleep apnea, this device might offer a more convenient way to monitor your sleep at home.
Redwood City, CaliforniaAges 12 years+ - NCT07475052Enrolling by invitation
Heart rate monitoring to predict biologic therapy response in IBD
This study tests whether a wearable heart rate monitor can help predict how well biologic medications work for people with Crohn's disease or ulcerative colitis. If you are starting infliximab or vedolizumab for the first time, you may be eligible.
Xi'an, ShaanxiAges 18–75 - NCT07465497Enrolling by invitation
Preventing Chemo Brain with Prebiotics and Synbiotics
This trial tests whether taking a special blend of prebiotics and synbiotics (friendly bacteria and food for them) can help prevent or reduce memory and thinking problems that sometimes happen during chemotherapy for breast cancer.
Zapopan, JaliscoAges 18 years+ - NCT07463430Enrolling by invitationPhase 4
Suzetrigine for pain after non-mastectomy breast surgery
This trial tests a new pain medication, suzetrigine, for people having breast surgery (not mastectomy) who are expected to have moderate pain. It checks if this drug works well compared to standard options.
San Diego, CaliforniaAges 18 years+ - NCT07456826Enrolling by invitationPhase 4
Comparing two eye numbing gels for shots
This trial tests a new eye-numbing gel against the standard numbing method to see which works better for patients getting regular anti-VEGF injections in the eye.
Tyler, TexasAges 18 years+ - NCT07456085Enrolling by invitationPhase 3
Rivaroxaban vs warfarin for mechanical heart valves
This trial compares a newer blood thinner (rivaroxaban) to the standard one (warfarin) for people with mechanical heart valves who have had clots or bleeding while on warfarin, or who cannot easily monitor their INR levels. It aims to see if rivaroxaban is safer and more effective.
Rawalpindi, Punjab ProvinceAges 18 years+ - NCT07443202Enrolling by invitationPhase 2
Lotilaner eye gel for ocular rosacea
This trial tests whether an eye gel containing lotilaner can help people with moderate to severe ocular rosacea, a condition that affects the eyes and eyelids. It may reduce symptoms like redness, irritation, and swelling.
Houston, TexasAges 18 years+ - NCT07442448Enrolling by invitationPhase 4
Study of Finerenone for heart and kidney health in diabetes
This trial tests a medication called Finerenone to see if it can improve heart structure and function in people with both diabetic kidney disease and heart failure. If you have type 2 diabetes, kidney problems, and heart failure with preserved pumping function, this study may explore a new treatment option for you.
TaipeiAges 18 years+ - NCT07436325Enrolling by invitation
Comparing gum health for two types of baby tooth crowns
This trial compares how gum health holds up with zirconia vs. stainless steel crowns on baby molars in children aged 3–7. It helps find which crown type may be better for keeping gums healthy.
Buraidah, Al-Qassim ProvinceAges 3–7 - NCT07431658Enrolling by invitation
Diet and stress effects on omalizumab response in chronic hives
This study looks at how diet and oxidative stress (a type of cell damage) affect the severity of chronic hives and how well patients respond to the medication omalizumab (Xolair). It may help find ways to improve treatment by understanding these factors.
IstanbulAges 18–65 - NCT07424508Enrolling by invitation
Adaptive brain stimulation for Parkinson's movement symptoms
This trial tests a new type of deep brain stimulation that adapts to your movements to improve walking, balance, and tremors. It is for people with Parkinson's disease who have had symptoms for at least 3 years, are 21 to 75 years old, and already have a special study brain-stimulation device implanted.
San Francisco, CaliforniaAges 21–75 - NCT07420075Enrolling by invitation
Alzheimer's registry for people with memory problems
This registry collects information from people with mild cognitive impairment or Alzheimer's disease who are starting a new medication. It helps researchers learn more about these conditions and their treatments over time.
Waltham, MassachusettsAges 18 years+ - NCT07405099Enrolling by invitation
Pancreas surgery risks in kidney failure patients
This study looks at the risks of pancreas surgery in people with end-stage kidney disease (kidney failure). It aims to help doctors understand how safe these surgeries are for patients on dialysis or with kidney problems.
Ages 20–75 - NCT07396025Enrolling by invitation
Study of surgery for blocked carotid arteries
This trial looks at how well surgery and diagnostic tests work for people with a blocked carotid artery (the main artery in the neck that supplies blood to the brain). It may help if you have reduced blood flow to part of your brain and are able to understand instructions and communicate.
AstanaAges 18 years+ - NCT07395232RecruitingPhase 3
Testing a new drug for allergic eye disease (AKC)
This study tests a new medication called DFL24498 for people with atopic keratoconjunctivitis (AKC), a severe allergic eye condition. The goal is to see if it reduces itching, discomfort, and eye redness safely.
Jacksonville, FloridaAges 18–65 - NCT07394634Enrolling by invitation
Using Your Own Tooth as a Bone Graft After Extraction
This study tests whether using your own extracted tooth (processed into a graft) helps preserve the bone in the socket after extraction, so a dental implant can be placed later. It is for people who need a tooth pulled and are healthy enough for implant surgery.
Jenjarum, SelangorAges 18 years+ - NCT07393373Enrolling by invitationPhase 2
Long-term study of infigratinib in children with hypochondroplasia
This study is for children with hypochondroplasia who already completed the ACCEL 2/3 trial. It tests the long-term safety and effects of the study drug infigratinib, and gives continued access to the treatment.
Oakland, CaliforniaAges 3–18 - NCT07388069Enrolling by invitationPhase 1/Phase 2
TN-001 eyedrops for progressive keratoconus
This trial tests a new eyedrop (TN-001) for people with keratoconus that is getting worse. The drops are applied twice a day to try to stop the cornea from thinning and bulging further.
Brisbane, QueenslandAges 18–40
Hear when a new No Disease or Condition is Being Studied trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for no disease or condition is being studied?
- Yes. Clin2 currently lists 18,647 recruiting no disease or condition is being studied studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a no disease or condition is being studied trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a no disease or condition is being studied trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.